BioSpace News Archive

Bracco Imaging S.p.A., and Shanghai Hengrui Pharmaceuticals Co. Ltd.,have signed today a collaboration agreement on new R&D activities in China.

RSV affects 33 million children globally and leads to approximately 120,000 childhood deaths every year1 In the United States approximately 177,000 older adults are hospitalized annually because of RSV2

Keynote at Drug Discovery Innovation Programme and Company Presentation at JMP Securities Life Sciences Conference

Covalon wins every single Vascular Access dressing category for the next three years in the Gulf Cooperation Council States in the Middle East

LuViva proved to be the more sensitive test, finding cervical cancer missed by Pap and HPV tests.

NanoSomiX, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the company’s first patent covering its groundbreaking proprietary exosome isolation and biomarker detection technology.

Dr. Dror Paley, MD, FRCSC uses new minimally invasive system to treat patients for stature lengthening and limb reconstruction.

Immunocore Limited, a leading T cell receptor (TCR) company focused on delivering first-in-class biological therapies that have the potential to transform lives, today announces that new data from its phase I/II dose escalation trial of its wholly-owned, lead programme, IMCgp100, in metastatic uveal melanoma (mUM) will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on 4 June 2018.

Startup to Advance Research Tools Development and Add Jobs

AKB-4924 is a once-daily, oral, gut-restricted HIF-1 alpha stabilizer that has been shown to improve disease indices in multiple models of inflammatory bowel disease.